0
POPSNew Treatment for Alzheimer’s Disease? In July 2003 some treatments for Alzheimer's treatments were brought to attention at the Alzheimer’s Association International Conference on Alzheimer’s disease (ICAD 2008). Some of these treatments showed great potential.
29
POPSPotential Alzheimer's, Parkinson's Cure Found In Century-old Drug Also impressed is one of Dr. Atamna's co-authors, Bruce Ames, PhD, a senior scientist at Children's and world-renowned expert in nutrition and aging. "What we potentially have is a wonder drug." said Dr. Ames. "To find that such a common and inexpensive drug can be used to increase and prolong the quality of life by treating such serious diseases is truly exciting." Dr. Atamna's research is the first to show that low concentrations of the drug have the ability to slow cellular aging in cultured cells in the laboratory and in live mice. He believes methylene blue has the potential to become another commonplace low-cost treatment like aspirin, prescribed as a blood thinner for people with heart disorders.
6
POPSPhysicians Create List of Who Will Live and Die Who is Out of Luck? It's being recommended that every hospital choose a triage team to decide who will get lifesaving treatment and who will not, but the guidelines already spell out some people who are supposed to be denied care. They include: * People older than 85 * People with severe trauma, such as critical injuries from car crashes and shootings * Severely burned patients older than 60 * People with severe mental impairment, such as advanced Alzheimer's disease * People with severe chronic disease, such as advanced heart failure, lung disease or poorly controlled diabetes
11
POPSExciting new Alzheimer's Research Prior to injecting the drug, the cognitive ability of the patient was measured. Researchers said he was unable to handle simple arithmetic and could not remember the names or even two animals. Just 10 minutes after he was injected with the new molecule, he was calmer and was able to recall his place of residence.
0
POPSEpix Soars 50% On Alzheimer's Data These are promising results, but investors should be cautious: The Alzheimer's field is littered with failed attempts at developing a treatment. Late-stage results often don't match the promise seen in mid-stage trials. Still, this is better than the approved drugs in this field can do, and a reason to watch Epix.
0
POPSMore Pain In Japan Both Takeda and Eisai were hit hard by negative news about the U.S. prospects for their experimental medicines.
2
POPSNew Imaging may detect Alzheimer's early. Use of scans which show areas of change in function rather than atrophy and irreversible damage already done. May be very useful in diagnosis and treatment in early stages of Alzheimer's.
0
POPSLawmakers Baffled That Scientests and Doctors Might Know Something About Drugs! So turns out all that smoking you did as a kid.. helped you out. But most of us already knew that when we smoked and our nausea went away or instead of wandering the house at four in the morning wishing there was a drug that actually worked for insomnia, we puffed our pipes and had the best sleep of our lives. Cheers to Norml.org for bringing this to lawmaker's attention..
6
Pops
Newest Clips
Latest Comments
Most Pops
Print
Save
Turn on live update